Inactive Instrument

Analyst Reco. ageas SA/NV Other OTC

Equities

AGEAS : Solid FY23, with massive deal speculation on top	29/02
Fitch Confirms Ageas Rating on Strong Company Profile, Profitability	14/11	MT
AGEAS : UBS maintains sell recommendation ahead of investor day	14/11	CF
AGEAS : EPS upgrade (2023: +23.0%, 2024: +25.6%)	06/11
AGEAS : Ageas' new IFRS 17 model	06/11
AGEAS : H1 23: not so bad a quarter, with mixed sentiments from China	30/23/30
AGEAS : EPS upgrade (2022: +17.5%, 2023: +7.4%)	23/23/23
Fitch Affirms Ageas's IFS at 'AA-'; Outlook Stable	28/22/28	AQ
Fitch Maintains Ageas' Insurer Financial Strength Rating on Solid Business Profile	28/22/28	MT
S&P Global Affirms Ageas' Ratings On 'Resilient' Financial Performance Amid Surging Inflation	23/22/23	MT
AGEAS : Decent results but some negative signals	11/22/11
AGEAS : A very convincing set of results	11/22/11
Fitch Affirms Ageas's IFS at 'AA-'; Outlook Stable	15/22/15	AQ
Fitch affirms Ageas’s AA- Insurer Financial Strength Rating with a Stable Outlook	15/22/15	GL
Fitch affirms Ageas’s AA- Insurer Financial Strength Rating with a Stable Outlook	15/22/15	AQ
Fitch Reiterates Belgian Insurer Ageas' Rating, Stable Outlook On Strong Financial Performance	15/22/15	MT
AGEAS : Surprising Non-Life and turmoiled Asia	12/22/12
AGEAS : Strong results lacking confidence	10/21/10
AGEAS : Tough times, believed to be temporary	11/21/11
Ageas / : Fitch Lifts Ageas to AA- on Strong Performance Amid COVID-19	28/21/28	MT

No results for this search

AGEAS : Solid FY23, with massive deal speculation on top

February 29, 2024 at 07:02 pm IST